Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

78.86 -2.34 (-2.88%)
Official Closing Price Updated: 4:10 PM EDT, Sep 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,215,203
Open 80.32
Bid (Size) 78.55 (1)
Ask (Size) 78.61 (5)
Prev. Close 81.20
Today's Range 77.54 - 80.62
52wk Range 61.78 - 134.77
Shares Outstanding 861,750
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks May Be Nearing A Breaking Point
We are seeing high yield spreads widen, and looking at the ratio of the SHY to HYG; it is clear that we surpassed the June highs. 
Via Talk Markets
Can Healthcare Stocks Continue To Outperform?
Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis. 
Via Talk Markets

Performance

YTD
-31.69%
-31.69%
1 Month
-6.07%
-6.07%
3 Month
+5.43%
+5.43%
6 Month
-13.03%
-13.03%
1 Year
-38.27%
-38.27%

More News

Read More
Rare Economic/Technical Signal Has Only Flashed 9 Times In Last 54 Years
Via Talk Markets
3 Biotech Stocks to Buy Now for Extraordinary Gains
Via InvestorPlace
AskSlim Market Week - Friday, July 22
Via Talk Markets
UUP ETF – Trade Setup Of The Week
Via Talk Markets
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
Via Investor's Business Daily
The Three Best Anti-Aging Stocks to Buy in September
Via InvestorPlace
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
Via InvestorPlace
5 Monster Stock Market Predictions For The Week Of Sept. 12
Via Talk Markets
Stocks Drop On August 6 As Financial Conditions Tightening More
Via Talk Markets
REITs And Utilities Show Glimmer As The S&P Wilts
Via Talk Markets
Healthcare Sector Still Looks Good But Lacks Momentum
Via Talk Markets
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
Via Benzinga
Whither Small Caps After Fed’s Tough Talk?
Via Talk Markets
3 Investing Themes For The Next 3 Years
Via Talk Markets
“Wrong Side Of The Wave” Stock Market (And Sentiment Results)
Via Talk Markets
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation?
Via Talk Markets
Exploding Interest Rates May Finally Suck Stocks Lower
Via Talk Markets
Small Cap Biotechs Perk Up On Dealmaking
Via Talk Markets
Stocks Stall On August 1, As Stagflation Appears To Have Finally Arrived
Via Talk Markets
Bullish Expanding Falling Wedge
Via Talk Markets
The 3 Best Market Sectors for the Second Half of 2022
Via InvestorPlace
Chris Stapleton “Starting Over” Stock Market (And Sentiment Results)
Via Talk Markets
Broad Market Rallies Despite Currency Headwinds
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.